3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
162
Myelodysplastic Syndromes
46
Leukemia, Myelomonocytic, Chronic
26
Leukemia
16
Myeloproliferative Disorders
11
Recurrence
9
Hematologic Neoplasms
8
Leukemia, Biphenotypic, Acute
7
Primary Myelofibrosis
6
Neoplasms
6
Lymphoma, T-Cell, Peripheral
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Anemia, Refractory, with Excess of Blasts
5
Neoplasm, Residual
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Monocytic, Acute
4
Hematologic Diseases
4
GATA2 Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Sarcoma
2
Interventions
Cisplatin
32
Gemcitabine
21
Radiotherapy, Intensity-Modulated
16
toripalimab
14
Capecitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Radiotherapy
7
Drug Therapy
7
pembrolizumab
6
Platinum
6
Nivolumab
6
Immune Checkpoint Inhibitors
6
1,2-diaminocyclohexaneplatinum II citrate
6
Docetaxel
5
tislelizumab
4
spartalizumab
4
camrelizumab
4
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
nimotuzumab
2
fludarabine
2
atezolizumab
2
Taxes
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Azacitidine
×
1 year
×
Clear all
No trials found.